Clinical Trials Browser

Prostatic Neoplasms

NCT01079793 2020-08-20

Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgery

Phase 1/2 Withdrawn

Genitourinary

Prostatic Neoplasms

NCT00672009 2018-10-24

A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer

Phase 2 Terminated

11 enrolled

Genitourinary

Adenocarcinoma, Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Glandular and Epithelial, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT00923130 2018-04-17

Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer

Phase 2 Completed

30 enrolled 12 charts

Genitourinary

Carcinoma, Renal Cell

NCT01012362 2017-12-28

Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Phase 1 Terminated

31 enrolled 12 charts

BreastGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma

NCT00331344 2017-10-31

Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy

Phase 1/2 Completed

100 enrolled 10 charts

Genitourinary

Prostatic Neoplasms

NCT00058084 2017-02-23

Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer

Phase 2 Completed

80 enrolled

Genitourinary

Prostatic Neoplasms

NCT00331643 2014-11-14

Ixabepilone in Treating Young Patients With Refractory Solid Tumors

Phase 2 Completed

120 enrolled

CNSGenitourinarySarcoma

Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma, Sarcoma, Synovial, Neuroectodermal Tumors, Primitive, Peripheral

NCT00087139 2014-05-09

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

Phase 2 Completed

124 enrolled 10 charts

Genitourinary

Prostatic Neoplasms

NCT00016393 2013-06-24

BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 2 Completed

Genitourinary

Prostatic Neoplasms

NCT00025194 2013-06-24

Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer

Phase 1/2 Completed

Genitourinary

Prostatic Neoplasms

NCT00070096 2013-06-24

Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors

Phase 2 Completed

29 enrolled

CNSGenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

NCT00182702 2013-03-25

Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer

Phase 2 Completed

37 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT00021099 2013-01-24

Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer

Phase 2 Completed

45 enrolled

Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00030992 2012-08-20

BMS 247550 to Treat Kidney Cancer

Phase 2 Completed

102 enrolled 10 charts

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00030108 2012-03-15

Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy

Phase 1 Completed

30 enrolled

CNSGastrointestinalGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmSarcoma

Familial ependymoma, Ovarian Germ Cell Cancer, Astrocytoma, Kidney Neoplasms, Leukemia, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Oligodendroglioma, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Teratoma, Testicular Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Eosinophilic, Acute, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer

Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgery

A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer

Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer

Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy

Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer

Ixabepilone in Treating Young Patients With Refractory Solid Tumors

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer

Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors

Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer

Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer

BMS 247550 to Treat Kidney Cancer

Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy